About This Calculator

The Physostigmine Dose Calculator provides recommended dosing for treating severe anticholinergic toxicity in adult and pediatric patients. Physostigmine is a reversible acetylcholinesterase inhibitor that can reverse both central and peripheral signs of anticholinergic poisoning. This tool calculates the appropriate initial dose and provides key parameters for safe administration based on patient type and weight.

Disclaimer: This tool is for educational purposes only and is not a substitute for professional clinical judgment. Always consult a clinical toxicologist or a regional Poison Control Center for guidance. Verify all calculations independently before administration.

Outputs Explained

The calculator provides a summary of recommended dosing parameters after you enter patient information. The key outputs include:

• Recommended Initial Dose: The starting dose in milligrams (mg). For pediatric patients, this is a weight-based calculation (0.02 mg/kg) with a maximum cap to prevent overdose. For adults, a standard starting dose is recommended.
• Administration Route & Rate: Specifies that physostigmine should be given intravenously (IV) and administered slowly (e.g., over at least 5 minutes) to minimize the risk of cholinergic side effects like seizures and bradycardia.
• Repeat Dosing Interval: Guidance on how frequently a dose can be repeated if the desired clinical effect is not achieved.
• Maximum Cumulative Dose: The total recommended maximum dose for a full course of treatment to avoid toxicity.
• Bedside Precautions: A critical reminder to have atropine, the reversal agent for physostigmine, immediately available at the bedside to manage potential cholinergic crisis.

How to Use the Calculator

Follow these simple steps to determine the recommended physostigmine dose:

1. Select Patient Type: Choose whether the patient is an “Adult” or “Pediatric”. This is crucial as the dosing strategies differ significantly.
2. Enter Patient Weight: Input the patient’s weight into the designated field. You can toggle between kilograms (kg) and pounds (lbs) for convenience.
3. Review the Results: The calculator will automatically display the recommended dosing information based on your inputs. No “calculate” button is needed. The results update in real-time.

Dosing Overview

The administration of physostigmine requires careful consideration of the patient population and adherence to established protocols to ensure safety and efficacy.

Adult Dosing

For adults with severe anticholinergic toxicity, the typical initial dose is 0.5 to 2 mg administered via slow IV push over at least 5 minutes. The dose can be repeated every 10 to 30 minutes as needed until symptoms resolve or a maximum cumulative dose of 4 mg is reached.

Pediatric Dosing

For children, the dose is weight-based: 0.02 mg/kg, also given via slow IV push over at least 5 minutes. The initial dose is typically capped at a maximum of 0.5 mg to reduce risks. Doses may be repeated every 5 to 10 minutes, with a total cumulative dose not to exceed 2 mg.

Switching Therapies

Physostigmine is an antidote used for a specific, acute toxicologic emergency (anticholinergic poisoning). It is not a long-term or maintenance medication. The concept of “switching” to or from other chronic medications does not apply in this context. Treatment decisions are based on the patient’s immediate clinical response and resolution of toxicity. Supportive care is the mainstay of treatment, with physostigmine used for severe cases.

Missed Dose Information

Physostigmine is administered in a controlled, acute care setting (like an emergency department or ICU) under continuous monitoring. It is given on an “as-needed” basis in response to specific clinical signs, not on a scheduled dosing regimen. Therefore, the concept of a “missed dose” is not applicable.

Safety Alerts

Proper patient selection and monitoring are critical for the safe use of physostigmine.

Frequently Asked Questions (FAQ)

Why is the pediatric dose capped at 0.5 mg?

The 0.5 mg cap on the initial pediatric dose is a safety measure. While the dose is calculated based on weight (0.02 mg/kg), the cap prevents an unusually large initial dose in heavier children, reducing the risk of cholinergic side effects like bradycardia or seizures.

What happens if I enter a patient’s weight in pounds (lbs)?

The calculator automatically converts the weight from pounds to kilograms (kg) to perform the correct dose calculation, as medical dosing standards are based on the metric system. The output will show the patient’s weight in both units for clarity.

Can this calculator be used for a patient who overdosed on TCAs?

No. A tricyclic antidepressant (TCA) overdose with signs of cardiac toxicity (such as a QRS duration greater than 100 milliseconds on an ECG) is a major contraindication for physostigmine. In this setting, it can precipitate cardiac arrest.

Why is it critical to have atropine at the bedside?

Physostigmine can sometimes cause an excessive cholinergic response (cholinergic crisis), leading to severe bradycardia, bronchospasm, or seizures. Atropine is an anticholinergic agent and serves as a direct antidote to reverse these life-threatening side effects if they occur.

What is the importance of the slow administration rate?

Administering physostigmine slowly over at least 5 minutes is crucial to prevent rapid increases in acetylcholine levels in the central nervous system, which can lower the seizure threshold and cause profound bradycardia.

What are the signs of anticholinergic toxicity?

Common signs are summarized by the mnemonic: “Mad as a hatter” (delirium, confusion), “Blind as a bat” (dilated pupils), “Red as a beet” (flushed skin), “Hot as a hare” (fever), and “Dry as a bone” (dry mucous membranes, urinary retention).

What does the “SLUDGE” mnemonic stand for?

SLUDGE is a mnemonic for the signs of a cholinergic crisis, the primary adverse effect of physostigmine. It stands for Salivation, Lacrimation, Urination, Defecation, GI upset, and Emesis. It signals overstimulation of the parasympathetic nervous system.

Is there a difference in the maximum cumulative dose for adults and children?

Yes. The generally accepted maximum cumulative dose for adults is 4 mg, while for pediatric patients it is 2 mg. This reflects differences in metabolism and body mass, aiming to achieve therapeutic effects while minimizing toxicity.

References

1. Hoffman RS, Howland M, Lewin NA, Nelson LS, Goldfrank LR, eds. Goldfrank’s Toxicologic Emergencies. 11th ed. McGraw-Hill; 2019.
2. Burns, M. J., Linden, C. H., & Traub, S. J. (2023). Anticholinergic poisoning. In S. J. Traub (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/anticholinergic-poisoning
3. Suchard, J. R. (2011). ACMT Position Statement: Physostigmine in Anticholinergic Toxicity. Journal of Medical Toxicology, 7(3), 183. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550278/
4. U.S. Food & Drug Administration (FDA). Drugs@FDA: Physostigmine Salicylate Injection Prescribing Information. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/